The pharmaceutical supply chain faces increasing complexities due to stringent regulatory requirements, rapid technological advancements, and the need for enhanced collaboration among stakeholders. This paper explores the advancement of Product Lifecycle Management (PLM) within this critical sector, highlighting its role in optimizing processes from drug development through to market delivery. We analyze the integration of PLM systems with emerging technologies such as artificial intelligence, blockchain, and IoT, which facilitate real-time data sharing and decision-making. By employing case studies and industry insights, we illustrate how effective PLM strategies can lead to improved compliance, reduced time-to-market, and enhanced product quality. This research underscores the necessity for pharmaceutical companies to adopt robust PLM frameworks to navigate the evolving landscape and meet the demands of patients and healthcare providers effectively. Implementing these frameworks not only streamlines operations but also fosters innovation, enabling companies to respond swiftly to market changes and emerging health challenges. This adaptability is crucial in a sector where regulatory requirements and consumer expectations are constantly shifting, making it essential for companies to stay ahead of the curve. By leveraging advanced technologies such as artificial intelligence and data analytics, organizations can further optimize their PLM processes, ensuring they remain agile and competitive in a fast-paced environment.
